Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline vs Ceftriaxone in Asian Adults with CABP
NCT01371838Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of ceftaroline fosamil in community-acquired bacterial pneumonia (CAP), sponsored by Pfizer. Started Dec 2011; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
community-acquired bacterial pneumonia (CAP)
Beyond the preview
Go deeper on NCT01371838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371838.